search
Back to results

Milk-induced Gastrointestinal Symptoms in Infants

Primary Purpose

Gastrointestinal Symptoms in Young Infants

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Formula milk free of cow's milk protein
Placebo
Sponsored by
University Hospital, Geneva
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Gastrointestinal Symptoms in Young Infants focused on measuring Constipation, Gastroeosphageal reflux, Colics

Eligibility Criteria

undefined - 6 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Infants 0-6 month old with at least one of the following symptoms : constipation, gastroesophageal reflux, colics

Exclusion Criteria:

  • Prematurity
  • exclusive breastfeeding
  • Other cause for symptoms

Sites / Locations

  • Département de l'enfant et de l'adolesent - Hôpitaux Universitaires de Genève

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Infant formula milk

Formula milk free of milk proteins

Arm Description

Infant formula milk adapted to age of infant

Milk-free formula milk adapted to age of infant

Outcomes

Primary Outcome Measures

Milk allergy in gastrointestinal diseases in young infants
Establish the role of milk proteins in gastrointestinal diseases in young infants

Secondary Outcome Measures

Diagnostic tests
Determine the diagnostic value of immunological tests in these pathologies

Full Information

First Posted
September 10, 2012
Last Updated
January 3, 2014
Sponsor
University Hospital, Geneva
search

1. Study Identification

Unique Protocol Identification Number
NCT01684319
Brief Title
Milk-induced Gastrointestinal Symptoms in Infants
Official Title
Prospective, Randomized, Double Blind and Placebo Controlled Study With the Aim to Establish the Role of Milk Proteins in Gastrointestinal Diseases (GERD, Constipation and Colics) of Young Infants and to Determine the Diagnostic Value of Immunological Tests in These Pathologies.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
August 2013 (Actual)
Study Completion Date
November 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Geneva

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Various digestive manifestations are common in infants less than 6 months and have a significant impact on morbidity and quality of life of the family. In a prospective study on more than 2800 Italian infants followed by 0-6 months of life, it was determined that 55% of these children had gastrointestinal symptoms such as regurgitation (23%), colics (20%), constipation (17%) or poor weight gain (15%). However, these symptoms are not very accurate, and their cause is often difficult to determine. Frequently, the pediatrician will exclude cow's milk protein in infant feeding, but without a clear etiological diagnosis was asked. This measure causes significant additional costs through the use of extensively hydrolyzed milk specifically for children and involves an elimination diet of all foods containing cow's milk sometimes for several years. This can negatively influence the growth of the child. If the involvement of milk in these pathologies is suggested by some early studies (35% for colics, 68% in constipation, 42% in gastroesophageal reflux), it is unclear in the current state of knowledge if these gastrointestinal symptoms are actually due to an "allergy" to milk. Moreover, there is no validated diagnostic test for non-IgE-mediated gut allergy. However, various tests have proven their effectiveness in the investigation of non IgE-mediated allergy (eg. LAT, patch tests) and will be used in this study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastrointestinal Symptoms in Young Infants
Keywords
Constipation, Gastroeosphageal reflux, Colics

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Infant formula milk
Arm Type
Placebo Comparator
Arm Description
Infant formula milk adapted to age of infant
Arm Title
Formula milk free of milk proteins
Arm Type
Active Comparator
Arm Description
Milk-free formula milk adapted to age of infant
Intervention Type
Dietary Supplement
Intervention Name(s)
Formula milk free of cow's milk protein
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Infant formula milk
Primary Outcome Measure Information:
Title
Milk allergy in gastrointestinal diseases in young infants
Description
Establish the role of milk proteins in gastrointestinal diseases in young infants
Time Frame
10 weeks
Secondary Outcome Measure Information:
Title
Diagnostic tests
Description
Determine the diagnostic value of immunological tests in these pathologies
Time Frame
10 weeks

10. Eligibility

Sex
All
Maximum Age & Unit of Time
6 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Infants 0-6 month old with at least one of the following symptoms : constipation, gastroesophageal reflux, colics Exclusion Criteria: Prematurity exclusive breastfeeding Other cause for symptoms
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe A Eigenmann, MD
Organizational Affiliation
Hôpitaux Unversitaire de Genève
Official's Role
Study Director
Facility Information:
Facility Name
Département de l'enfant et de l'adolesent - Hôpitaux Universitaires de Genève
City
Genève
State/Province
GE
ZIP/Postal Code
1211
Country
Switzerland

12. IPD Sharing Statement

Learn more about this trial

Milk-induced Gastrointestinal Symptoms in Infants

We'll reach out to this number within 24 hrs